Paper Details 
Original Abstract of the Article :
Oral opioids are the treatment of choice for chronic cancer pain. Morphine is the strong opioid of choice for the treatment of moderate to severe cancer pain according to guidelines from the World Health Organization (WHO). This recommendation by the WHO was derived from availability, familiarity to...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936259/

データ提供:米国国立医学図書館(NLM)

Oxycodone Controlled Release in Cancer Pain Management: A Oasis of Relief in the Desert of Pain

The world of chronic pain is often a desolate desert, where individuals struggle to find relief from persistent discomfort. Cancer pain, in particular, presents a unique set of challenges, requiring tailored approaches to manage the physical and emotional toll. This study explores the use of oxycodone controlled-release, a powerful opioid, in the management of cancer pain.

A Promising Solution in the Desert of Pain: Oxycodone Controlled Release

The authors provide a comprehensive overview of oxycodone's properties, highlighting its efficacy in controlling moderate to severe cancer pain. The study emphasizes that oxycodone's controlled-release formulation offers a sustained and predictable analgesic effect, potentially reducing the need for frequent dosing and minimizing the risk of side effects. This approach holds significant promise for improving pain management in cancer patients.

Finding Relief in the Desert: A New Frontier in Pain Management

This study provides a valuable contribution to the field of pain management, offering a promising alternative to traditional opioid therapies. The use of oxycodone controlled-release, with its sustained and predictable analgesic effect, has the potential to revolutionize how we approach cancer pain management, bringing relief to those who suffer from this debilitating condition. Further research is needed to fully understand the benefits and potential risks associated with this medication, but it presents a hopeful avenue for improving patient care.

Dr. Camel's Conclusion

The use of oxycodone controlled-release in cancer pain management offers a glimmer of hope in the vast desert of pain. This study highlights the potential of this medication to provide sustained relief, improving the quality of life for individuals battling cancer pain. Further research is crucial to optimize its use and ensure the safety and efficacy of this promising therapy.

Date :
  1. Date Completed 2011-07-14
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

18360598

DOI: Digital Object Identifier

PMC1936259

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.